HOME >> BIOLOGY >> NEWS
Lecture on ecology of infectious diseases

Urbanization results in the fragmentation of native habitats, which dramatically alters the rate of transmission and spread of infectious diseases, scientists are finding.

Case in point: Native grasslands throughout the western United States are becoming the most rapidly urbanized ecosystems in the country. Black-tailed prairie dogs, an imperiled species in western states, are increasingly found in these urban grasslands. In Boulder County, Colo., for example, nearly two-thirds of all prairie dog colonies are within a half-mile of urban development.

Prairie dogs are highly susceptible to plague, a disease that has also afflicted humans for centuries. Plague outbreaks in prairie dog colonies result in the death of nearly all prairie dogs in the colony, yet little is known about the factors that influence where and when plague epidemics will strike. Because of the close proximity of prairie dog colonies to human dwellings, concern is growing that prairie dogs may be a threat to public health.

With funding from the joint National Science Foundation-National Institutes of Health Ecology of Infectious Diseases Program, biologist Sharon Collinge of the University of Colorado at Boulder used records from two decades of plague outbreaks in prairie dogs in Boulder County to evaluate the importance of landscape setting in predicting these outbreaks.

Plague epidemics in prairie dogs, she found, were related to the surrounding landscape in unexpected ways: prairie dog colonies in urban settings were no more or less likely to experience a plague outbreak than such colonies in more rural settings. Significantly, plague outbreaks tended not to occur in colonies that were surrounded by roads, streams or lakes, suggesting that these landscape features may alter the conditions necessary for plague transmission or serve as barriers to movement of the disease.

By identifying the ecological components of plague outbreaks, Collinge wil
'"/>

Contact: Cheryl Dybas
cdybas@nsf.gov
703-292-7734
National Science Foundation
10-Sep-2004


Page: 1 2

Related biology news :

1. APS announces 2004 Distinguished Lecturer Awards
2. Webcast of NSF Director Rita Colwells Chafee Memorial Lecture
3. APS announces its 2003 Distinguished Lectureships
4. Lecture on anthrax by leading researcher
5. APS announces its 2002 Distinguished Lectureships
6. Robert S. Langer to present the 2001 Ullyot Public Affairs Lecture
7. International Expert To Discuss Ramifications At Local Lecture...Tracking Contaminants In The Mighty Mississippi And Other Large Rivers Worldwide
8. 1996-1997 Human Genome Lecture Series
9. Better living through urban ecology
10. Wolf reintroduction reshapes Yellowstone ecology
11. Articles on remote sensing in ecology published in BioScience

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Lecture ecology infectious diseases

(Date:8/19/2015)...  VOXX International Corporation (Nasdaq: VOXX ) ... Definitive Agreement to purchase the assets, inclusive of ... EyeLock through an acquiring entity.  Upon consummation of ... in the acquiring entity. The closing of the ...  Expanding on its existing supply chain and distribution ...
(Date:8/18/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ... "Global Biometric Authentication & Identification Market: Focus On ... 2015-2020" report to their offering. ... market is expected to grow at an estimated ... generate over $25 billion (approximately) by 2020 as ...
(Date:8/12/2015)... Aug. 12, 2015   MedNet Solutions , an ... spectrum of clinical research, is proud to announce that ... comprehensive SaaS-based eClinical technology platform, has led the way ... two quarters of 2015.   Q2 2015 and Q1 ... measured by contract value sold in the company,s 15 ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2MedNet Solutions Experiences Explosive Corporate Growth 2
(Date:9/2/2015)... -- Biovista Inc. is glad to announce ... science challenge, a global competition hosted by the Rare ... the latest life science innovations and technologies. ... capability to support Steven Laffoon and his ... Niemann-Pick Disease Type A (NPA), a rare and fatal ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, ... enrolled in the multicenter Phase 2 clinical trial ... long-term treatment of recurrent subfoveal choroidal neovascularization secondary ... is a unique vascular endothelial growth factor (VEGF) ... implant. "This landmark proof-of-concept study will ...
(Date:9/2/2015)... -- Aytu BioScience, Inc. (OTCQB: AYTU), a specialty healthcare ... conditions, announced today that it has closed the final ... raising a total of $5.175 million, which includes proceeds ... Josh Disbrow , Chief Executive Officer of ... to be used to conduct clinical studies for both ...
(Date:9/2/2015)... , September 2, 2015 ... ("BioLight" or the "Company"), a firm that invests ... and cancer diagnostics, announced today that presentations highlighting ... will be delivered at the Ophthalmology Futures European ... Society of Cataract & Refractive Surgeons ("ESCRS"), both ...
Breaking Biology Technology:Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3
Cached News: